Clinical trial

European Pregnancy and Paediatric Infections Cohort Collaboration: Paediatric Protocol

NCT04677842

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2013-01-01

PhaseN/A

Study timeline

Study start (actual)2013-01-01Date precision: day

Registry last updated2020-12-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Tuberculosis Infectionunresolved

Hepatitis Cunresolved

Covid19unresolved

Interventions

ART TherapyDRUG

Sponsors & collaborators

PENTA Foundationlead sponsor

University College, Londoncollaborator

Centre Hospitalier Universitaire Saint Pierrecollaborator

German Pediatric and Adolescent HIV Cohort (GEPIC), GERMANYcollaborator

Greece Cohort, GREECEcollaborator

Register for HIV infection in children, ITALYcollaborator

ATHENA ,THE NETHERLANDScollaborator

Polish Paediatric Cohort, POLANDcollaborator

HSM/CHLN Lisbon, PORTUGALcollaborator

Centro Hospitalar do Portocollaborator

Victor Babes Hospital Cohort, Bucharest, ROMANIAcollaborator

Republican Hospital of Infectious Diseases, St Petersburg, RUSSIAcollaborator

Irkutsk AIDS Centre, RUSSIAcollaborator

The City HIV Centre, St Petersburg, RUSSIAcollaborator

CoRISpe-cat cohort of HIV-infected children, SPAINcollaborator

CoRISpe-S cohort of HIV-infected children, SPAINcollaborator

Karolinska Institutetcollaborator

Swiss Mother and Child HIV Cohort Study, SWITZERLANDcollaborator

Programs for HIV Prevention and Treatment (PHPT), THAILANDcollaborator

National Surveilliance of HIV in Pregnancy and Childhood and Collaborative HIV Paediatric Study (CHIPS)collaborator

Collaborative HIV Paediatric Study (CHIPS)collaborator

Ukraine Paediatric HIV Cohort, UKRAINEcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04677842 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.